Clinical Trial Update: TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update exploring thoracic radiotherapy (TRT) for extensive-stage small cell lung cancer after initial treatment with immune checkpoint …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer Extensive Stage

Drugs mentioned

• TRT

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: SCLC,Extensive Stage | Phase 2 | Status: UNKNOWN